Vault-13

NKGEN BIOTECH INC NKGN

COM · Common Stock · CUSIP 65488A101

18 institutional holders +4 vs Q1 2024
3,416,8733.4m shares reported held*
$4.2mreported value*
6 new 4 added 2 reduced 2 sold out net bought ≈ $505.5k (+398.0k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.24.

Trends to Q2 2024

Institutional holders

Managers reporting a position, each quarter

01020Q4 23: 10Q1 24: 14Q2 24: 1818Q4 23Q1 24Q2 24
Numbers
QuarterHolders
Q4 202310
Q1 202414
Q2 202418

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
10010Q1 24: 8 bought or addedQ1 24: 3 cut or sold outQ1 24Q2 24: 10 bought or addedQ2 24: 4 cut or sold outQ2 24
Numbers
QuarterBought or addedCut or sold out
Q1 202483
Q2 2024104

Biggest buyers

Diametric Capital, LP New +333,334+333.3k
UBS Group AG Added +32,728+32.7k
Virtu Financial LLC New +18,917+18.9k
BlackRock Inc. New +16,966+17.0k
GEODE CAPITAL MANAGEMENT, LLC Added +15,070+15.1k
NORTHERN TRUST CORP Added +13,360+13.4k
HRT FINANCIAL LP New +11,389+11.4k
STATE STREET CORP New +11,200+11.2k
Sequoia Financial Advisors, LLC Added +2,500+2.5k
BANK OF AMERICA CORP /DE/ New +50+50

Biggest sellers

Meteora Capital, LLC Reduced -39,626-39.6k
SUSQUEHANNA INTERNATIONAL GROUP, LLP Sold out -16,906-16.9k
Tower Research Capital LLC (TRC) Reduced -939-939
WELLS FARGO & COMPANY/MN Sold out -48-48

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Song Paul Y. 13D · may seek influence new · filed 2025-05-12
Stated purposeThe securities were acquired for investment purposes and to align with the strategic direction of the Company. The Reporting Person, as President and CEO of NKGen Biotech, Inc., currently exercises influence over management, operations, and corporate policy. Except as described herein, the Reporting Person does not currently have any plans or proposals that relate to or would result in any of the actions enumerated in this Item 4, although the Reporting Person reserves the right to formulate such plans or proposals in the future. Full filing
54.3% new 63.7m 2025-05-12
CFIC-2015 NV Family Investments, LLC 13D · may seek influence new · filed 2025-06-02
Stated purposeThe securities were acquired for investment purposes. From time to time, the Reporting Persons and their affiliates may engage in discussions with management, the board of directors (the "Board"), and stockholders of the Issuer and other relevant parties regarding business practices and governance policies of the Company. The Reporting Persons intend to monitor the performance and corporate governance of the Company, as well as the actions of the Company's management and Board and will assert stockholder rights as deemed necessary. Other than as described in this paragraph, the Reporting Persons have no present plans or proposals that relate to or would result in any of the actions enumerated in Item 4 of Schedule 13D. Full filing
47.2% new 63.2m 2025-06-02
PATHSTONE FAMILY OFFICE, LLC 13G · institution new · filed 2025-02-28 7.9% new 2.8m 2025-02-28
METEORA CAPITAL, LLC 13G · institution -1.7 pts · filed 2025-05-15 6.1% -1.7 pts 2.8m 2025-05-15

Holders, Q2 2024

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Meteora Capital, LLC 0.28% of their portfolio Boca Raton, FL 1,167,9901.2m $1.5m $1.5m 0.28% Reduced -39.6k -39,626
2 Polar Asset Management Partners Inc. 0.03% of their portfolio TORONTO, A6 1,080,0001.1m $1.3m $1.3m 0.03% Unchanged
3 UNIVERSITY OF CHICAGO 0.54% of their portfolio CHICAGO, IL 550,000550.0k $698.5k $698.5k 0.54% Unchanged
4 Diametric Capital, LP 0.23% of their portfolio BOSTON, MA 333,334333.3k $423.3k $423.3k 0.23% New
5 GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio BOSTON, MA 68,43968.4k $86.9k $86.9k 0.00% Added +15.1k +15,070
6 VANGUARD GROUP INC 0.00% of their portfolio Valley Forge, PA 53,80453.8k $68.3k $68.3k 0.00% Unchanged
7 UBS Group AG 0.00% of their portfolio ZURICH, V8 43,81743.8k $55.6k $55.6k 0.00% Added +32.7k +32,728
8 NORTHERN TRUST CORP 0.00% of their portfolio CHICAGO, IL 29,08229.1k $36.9k $36.9k 0.00% Added +13.4k +13,360
9 Virtu Financial LLC 0.00% of their portfolio New York, NY 18,91718.9k $24.0k $24.0k 0.00% New
10 Sequoia Financial Advisors, LLC 0.00% of their portfolio Akron, OH 18,50018.5k $23.5k $23.5k 0.00% Added +2.5k +2,500
11 BlackRock Inc. 0.00% of their portfolio New York, NY 16,96617.0k $21.5k $21.5k 0.00% New
12 HRT FINANCIAL LP 0.00% of their portfolio NEW YORK, NY 11,38911.4k $14.0k $14.0k 0.00% New
13 STATE STREET CORP 0.00% of their portfolio BOSTON, MA 11,20011.2k $14.2k $14.2k 0.00% New
14 Towneley Capital Management, Inc / DE 0.00% of their portfolio LAGUNA HILLS, CA 10,00010.0k $12.7k $12.7k 0.00% Unchanged
15 Tower Research Capital LLC (TRC) 0.00% of their portfolio NEW YORK, NY 2,8852.9k $3.7k $3.7k 0.00% Reduced -939 -939
16 Federation des caisses Desjardins du Quebec 0.00% of their portfolio LEVIS, A8 500500 $635 $635 0.00% Unchanged
17 BANK OF AMERICA CORP /DE/ 0.00% of their portfolio CHARLOTTE, NC 5050 $64 $64 0.00% New
18 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% Unchanged